Eagle Pharmaceuticals Market Cap 2013-2018 | EGRX
Eagle Pharmaceuticals market cap history and chart from 2013 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Eagle Pharmaceuticals market cap as of March 25, 2019 is $0.67B.
||Medical Products Manufacturing
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.